RecruitingOBSERVATIONAL

Giessen Stroke Registry

This study, called the Giessen Stroke Registry, is all about understanding and improving stroke care. Researchers are collecting information on patients who have had a sudden stroke to see how different treatments affect their recovery, health outcomes, and survival. They're particularly interested in emergency treatments, such as managing blood pressure, blood sugar, and breathing during intense therapies, and also how medications are used to prevent another stroke. By looking at what works well and what might not, the study aims to provide clearer guidance for doctors on the best ways to treat stroke patients, both immediately after a stroke and in the longer term.

At a glance

Status

Recruiting

Sponsor

University of Giessen

Enrolment target

2,000

Start

30 Nov 2023

Estimated completion

31 Dec 2027

Stroke, Acute Comorbidities and Coexisting Conditions Critical Care

What is this study about?

Stroke happens when the blood supply to part of your brain is cut off, either by a clot or a bleed. It's a very serious medical emergency. This study, called the Giessen Stroke Registry, is collecting important information from patients admitted to hospital for a sudden stroke. The main goal is to understand how different treatments given during and after a stroke affect how well people recover. The researchers want to find out which methods are most effective in helping patients get better, reduce long-term problems, and improve their chances of survival.

They're focusing on two main areas: immediate emergency treatment and ongoing care to prevent another stroke. During the acute phase (the first hours and days after a stroke), they're looking at things like how blood pressure, blood sugar, and breathing are managed, especially when patients are having treatments like 'clot-busting' drugs or procedures to remove clots. They also want to understand the best way to use blood-thinning medications to prevent future strokes, looking at when to start them, what kind to use, and the right dose.

By gathering and analysing all this real-world information, the study hopes to give doctors clearer evidence and arguments for or against certain treatment choices. This could lead to better guidelines and improved care for everyone affected by stroke in the future. It's about learning from current practices to make care even better.

Key takeaways

This study collects information about standard stroke treatments.
It aims to improve future stroke care by identifying effective approaches.
No new treatments or procedures are involved for participants.
Your regular medical care will not change if you participate.
Participation is for adults admitted for acute stroke.
All personal data is kept confidential and secure.

Who may be eligible?

To be part of this study, you would need to be an adult, aged 18 or older, who has been admitted to a hospital's Stroke Unit or Intensive Care Unit because of a sudden stroke. You would also need to be able to understand what the study involves and agree to take part, either yourself or through a legal representative if you can't make decisions on your own.

If you don't meet these basic requirements, then you wouldn't be able to join the study. The main idea is to include people who are experiencing an acute stroke and are receiving care in a specialist hospital unit.

It's important to remember that joining a study is a big decision, and you should always discuss it with your doctor or the study team to make sure it's right for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Have you been admitted to hospital recently for a sudden stroke?
Are you receiving care on a Stroke Unit or in Intensive Care?
Can you or your legal representative understand and agree to join the study?

Answer every question to see your result.

What does participation involve?

If you are asked to be part of the Giessen Stroke Registry, you won't be given any new or experimental treatments. Instead, the study will simply collect information about the usual care you receive for your stroke at the hospital. This includes details about your diagnosis, the treatments you get (like medications or procedures), how your health is monitored (such as blood pressure, blood sugar), and how you recover. This information will be gathered from your hospital notes and medical records. There are no extra visits, assessments, or medications specifically for this study. The study team will follow your progress based on your regular hospital care and any follow-up appointments you already have. The total duration of your participation would depend on how long the study continues to collect data on stroke patients.

Potential risks and benefits

There are no direct benefits to you from taking part in this study, as it only involves collecting information about your usual care and doesn't change your treatment. Similarly, there are no physical risks, as you won't undergo any extra tests or procedures. The main benefit of your participation is that the information gathered will help researchers understand and improve stroke care for future patients. All your personal data will be kept confidential. You have the right to withdraw from the study at any time without explaining why, and this will not affect the medical care you receive.

Locations (1)

Universitätsklinikum Gießen
Verified postcode
Giessen, Germany· Recruiting

Common questions

What is the main goal of this study?

The study aims to understand which stroke treatments work best to help patients recover and improve long-term outcomes.

Will I receive new medications or treatments in this study?

No, you will not receive any new or experimental treatments. The study just collects information about the standard care you already receive.

Who can take part in this study?

Adults aged 18 or over who have had a sudden stroke and are being treated in a hospital stroke unit or intensive care unit can potentially take part.

Will my personal information be kept private?

Yes, all your personal information will be kept confidential and handled securely by the study team.

Can I leave the study at any time?

Yes, you have the right to withdraw from the study at any point, and it will not affect your medical care.

How to find out more

Tobias Braun, M.D.

tobias.braun@neuro.med.uni-giessen.de +49641-985 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.